Skip to main content
FDA Approves Ponatinib for Upfront Ph+ ALL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA Approves Ponatinib for Upfront Ph+ ALL
User login
Username
Password
Reset your password
Concept
Lead
score
Acute Leukemia
1
1
Acute Lymphoblastic Leukemia
0
0.99
Chronic Myeloid Leukemia
0
0.49
Leukemia
0
0.47
Biologic Therapy
0
0.42
Tyrosine Kinase Inhibitor
0
0.98
Chemotherapy
0
0.35
Grant
0
0.35
Arrhythmia
0
0.34
Heart Failure (HF)
0
0.29
Antineoplastic Drug
0
0.24
Hypertension
0
0.24
Pain Management
0
0.24
Remission
0
0.24
Residual Disease
0
0.24
Abdominal Pain
0
0.2
Arthralgia
0
0.2
Peripheral Neuropathy
0
0.17
Constipation
0
0.14
Headache
0
0.14
Neutropenia
0
0.14
Toxicology
0
0.14
Abdomen
0
0.12
Edema
0
0.12
Fatigue
0
0.12
Fever
0
0.12
Fluid Retention
0
0.12
Heart
0
0.12
Hemorrhage
0
0.12
Mucositis
0
0.12
Nausea
0
0.12
Neuropathy
0
0.12
Pain
0
0.12
Paresthesia
0
0.12
Tyrosine Kinase
0
0.12
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.9
Edit Tags